Repurposing Antiepileptic Drugs for Cancer: A Promising Therapeutic Strategy
Open Access
- 14 April 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2673
Abstract
Epilepsy is a neurological disorder characterized by repeated convulsions. Antiepileptic drugs (AEDs) are the main course of therapy for epilepsy. These medications are given according to each patient’s personal medical history and the types of seizures they suffer. They have been employed for decades to manage epilepsy, thus delivering relief from seizures through numerous mechanisms of action. Aside from their anticonvulsant attributes, current evidence suggests that certain AEDs may display potential inhibitory effects against cancer invasion and metastasis. This review explored the complicated interactions between the modes of action of AEDs and the pathways causing cancer, and the potential impact of AEDs on the invasion and metastasis of various forms of cancer, while addressing their associated side effects. For example, valproic acid inhibits histone deacetylase, causing hyperacetylation of genes, especially those regulating cell cycle, culminating in cell cycle arrest. Topiramate inhibits carbonic anhydrase, thus disrupting the acidic microenvironment needed for cancer cells to thrive. Lacosamide increases the slow inactivation of the voltage gated Na+ channel, thus inhibiting the growth, proliferation, and metastasis of many cancers. Although drug development is a complex task due to regulatory, intellectual property, and economic challenges, researchers are exploring drug repurposing tactics to overcome these challenges and to find new therapeutic alternatives for diseases like cancer. Thus, drug repurposing is considered among the most effective ways to develop drug candidates using novel properties and therapeutic characteristics, and this review also discusses these issues.Keywords
All Related Versions
This publication has 142 references indexed in Scilit:
- Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathwaysCell Biochemistry and Function, 2024
- Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modelingAnnals of Clinical and Translational Neurology, 2023
- Significant predictors for topiramate pharmacokinetics: a systematic review of population pharmacokinetic studiesJournal of Pharmacy Practice and Research, 2022
- Tumor metastasis: Mechanistic insights and therapeutic interventionsMedcomm, 2021
- Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancerMolecular Biology Reports, 2021
- The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyondCancer and Metastasis Reviews, 2019
- Lacosamide at therapeutic concentrations induces histone hyperacetylation in vitroEpilepsia Open, 2018
- Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantificationJournal of Cancer Research and Clinical Oncology, 2016
- Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivationJournal of Neuroscience Research, 2012
- VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating SurvivinMolecular and Cellular Biochemistry, 2011